title: Neutralizing antibodies against interferon-β do not predispose antibodies against natalizumab.
authors.affiliation: Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. pss@rh.regionh.dk
authors.forename: Per Soelberg
authors.initials: PS
authors.lastname: Sørensen
authors.forename: Nils
authors.initials: N
authors.lastname: Koch-Henriksen
authors.forename: Poul Erik Hyldgaard
authors.initials: PE
authors.lastname: Jensen
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D057134:Antibodies, Neutralizing / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016899:Interferon-beta / Q000276:immunology* / Q000627:therapeutic use*; D008137:Longitudinal Studies; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology; D000069442:Natalizumab; D013997:Time Factors
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D057134:Antibodies, Neutralizing; D000069442:Natalizumab; D016899:Interferon-beta